Percutaneous mitral balloon valvuloplasty (PMBV) was initially described by Inoue in 1984 as a novel percutaneous technique for the management of mitral stenosis. Intracardiac echocardiography was initially used in the 1980s but was not universally accepted due to its high-frequency transducers and problems with steerability and manipulation. In the 1990s technical improvements led to more gene...

A 26-YEAR-OLD symptomatic female patient with severe aortic and mitral valve stenoses underwent aortic and mitral valve balloon valvuloplasty in the same setting. Aortic balloon valvuloplasty was first performed retrogradely using a polyethylene 20-mm balloon (Mansfield, USA), and mitral valvuloplasty was performed antegradely through transseptal technique using an Inoue 28-mm balloon (Toray, J...

A 28-year-old woman with severe mitral stenosis underwent percutaneous mitral valvuloplasty at 26 weeks' gestation. Balloon dilation using a double 18-18 mm balloon resulted in improvement in mean mitral pressure gradient (32 to 8 mmHg) and in calculated mitral valve area (0.9 to 2.4 cm2) without complications and any evidence of fetal distress during procedures with an estimated radiation expo...

Currently Percutaneous Balloon Mitral Valvuloplasty has established itself as a standard treatment for patients with severe mitral stenosis. A patient with severe mitral stenosis was posted for the above procedure. After dilatation of mitral valvular apparatus the Accura balloon failed to deflate on repeated aspirations, probably due to rupture of internal lumen. Finally, a guide wire was passe...

b-type natriuretic peptide (bnp) level is known to increase in patients with rheumatic mitral stenosis. in this systematic review, we aimed to discuss the possible association between plasma bnp level and the success rate of percutaneous transvenous mitral commissurotomy. pubmed and scopus databases were searched systematically, using the following key terms: “b-type natriuretic peptide” or “bn...

INTRODUCTION The use of mitral balloon valvuloplasty as a percutaneous intervention for mitral stenosis has been shown to be efficacious. Cardiac tamponade is a rare but serious complication of this procedure. Despite the low incidence of this event, cardiac tamponade is well-reported in the literature. The management strategy of this complication involves pericardial drainage and correction of...

OBJECTIVES This study sought to investigate the changes induced on the pressure-area relation of the left atrium in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty. BACKGROUND Left atrial (LA) function is influenced by changes in LA afterload. The latter is increased in mitral stenosis as a result of increased resistance to blood flow imposed by the stenotic mitr...

rheumatic mitral valve stenosis is the most common form of organic heart disease encountered during pregnancy and continues to cause maternal and fetal mortality. medically refractory congestive heart failure due to mitral stenosis is a clinical challenge and its optimal management remains controversial. on the other hand due to hazard of x-ray to mother and fetus, there are some limitations fo...

Until recently, percutaneous catheter therapy for valvular heart disease was limited to catheter balloon valvuloplasty for aortic, mitral, or pulmonic stenosis. A number of new approaches to percutaneous valve therapy are now developing rapidly, including methods for catheter-based valve replacement and repair. Stent-mounted valve prostheses have been successfully implanted in the pulmonic and ...